176 related articles for article (PubMed ID: 15336311)
1. Progressive iron accumulation induces a biphasic change in the glutathione content of neuroblastoma cells.
Núñez MT; Gallardo V; Muñoz P; Tapia V; Esparza A; Salazar J; Speisky H
Free Radic Biol Med; 2004 Oct; 37(7):953-60. PubMed ID: 15336311
[TBL] [Abstract][Full Text] [Related]
2. Benzo[a]pyrene-induced elevation of GSH level protects against oxidative stress and enhances xenobiotic detoxification in human HepG2 cells.
Lin T; Yang MS
Toxicology; 2007 Jun; 235(1-2):1-10. PubMed ID: 17416446
[TBL] [Abstract][Full Text] [Related]
3. Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells.
Tirmenstein MA; Hu CX; Scicchitano MS; Narayanan PK; McFarland DC; Thomas HC; Schwartz LW
Toxicol In Vitro; 2005 Jun; 19(4):471-9. PubMed ID: 15826805
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of energy and redox states in the C6 glioma cells by buthionine sulfoxamine and N-acetylcysteine and the effect on cell survival to cadmium toxicity.
Yang MS; Yu LC; Pat SW
Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):56-61. PubMed ID: 17519112
[TBL] [Abstract][Full Text] [Related]
5. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of cellular glutathione by 3H-1,2-dithiole-3-thione as a possible treatment strategy for protecting against acrolein-induced neurocytotoxicity.
Jia Z; Misra BR; Zhu H; Li Y; Misra HP
Neurotoxicology; 2009 Jan; 30(1):1-9. PubMed ID: 19073213
[TBL] [Abstract][Full Text] [Related]
7. Glutathione oxidation and embryotoxicity elicited by diamide in the developing rat conceptus in vitro.
Hiranruengchok R; Harris C
Toxicol Appl Pharmacol; 1993 May; 120(1):62-71. PubMed ID: 8511783
[TBL] [Abstract][Full Text] [Related]
8. Induction of endogenous glutathione by the chemoprotective agent, 3H-1,2-dithiole-3-thione, in human neuroblastoma SH-SY5Y cells affords protection against peroxynitrite-induced cytotoxicity.
Cao Z; Hallur S; Qiu HZ; Peng X; Li Y
Biochem Biophys Res Commun; 2004 Apr; 316(4):1043-9. PubMed ID: 15044090
[TBL] [Abstract][Full Text] [Related]
9. What process causes nigral cell death in Parkinson's disease?
Jenner P
Neurol Clin; 1992 May; 10(2):387-403. PubMed ID: 1584181
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
11. Depletion of brain glutathione results in a decrease of glutathione reductase activity; an enzyme susceptible to oxidative damage.
Barker JE; Heales SJ; Cassidy A; Bolaños JP; Land JM; Clark JB
Brain Res; 1996 Apr; 716(1-2):118-22. PubMed ID: 8738227
[TBL] [Abstract][Full Text] [Related]
12. Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.
Hajieva P; Mocko JB; Moosmann B; Behl C
J Neurochem; 2009 Jul; 110(1):118-32. PubMed ID: 19486265
[TBL] [Abstract][Full Text] [Related]
13. Zinc toxicity in various lung cell lines is mediated by glutathione and GSSG reductase activity.
Walther UI; Wilhelm B; Walther S; Mückter H; Fichtl B
Biol Trace Elem Res; 2000; 78(1-3):163-77. PubMed ID: 11314976
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine-induced nitric oxide increase and cell death is dependent on cellular GSH depletion in A172 human glioblastoma cells.
Park BC; Park SH; Paek SH; Park SY; Kwak MK; Choi HG; Yong CS; Yoo BK; Kim JA
Toxicol Lett; 2008 Apr; 178(1):52-60. PubMed ID: 18359172
[TBL] [Abstract][Full Text] [Related]
15. Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia.
Auchère F; Santos R; Planamente S; Lesuisse E; Camadro JM
Hum Mol Genet; 2008 Sep; 17(18):2790-802. PubMed ID: 18562474
[TBL] [Abstract][Full Text] [Related]
16. Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies.
Jagatha B; Mythri RB; Vali S; Bharath MM
Free Radic Biol Med; 2008 Mar; 44(5):907-17. PubMed ID: 18166164
[TBL] [Abstract][Full Text] [Related]
17. Astrocytes protect MN9D neuronal cells against rotenone-induced oxidative stress by a glutathione-dependent mechanism.
Cao Q; Wei LR; Lu LL; Zhao CL; Zhao HY; Yang H
Sheng Li Xue Bao; 2007 Jun; 59(3):253-9. PubMed ID: 17579777
[TBL] [Abstract][Full Text] [Related]
18. Direct evidence for glutathione as mediator of apoptosis in neuronal cells.
Nicole A; Santiard-Baron D; Ceballos-Picot I
Biomed Pharmacother; 1998; 52(9):349-55. PubMed ID: 9856280
[TBL] [Abstract][Full Text] [Related]
19. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease.
Chinta SJ; Andersen JK
Free Radic Biol Med; 2006 Nov; 41(9):1442-8. PubMed ID: 17023271
[TBL] [Abstract][Full Text] [Related]
20. Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease?
Andersen JK
Novartis Found Symp; 2001; 235():11-20; discussion 20-5. PubMed ID: 11280021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
